Technical Analysis for IMGO - Imago BioSciences, Inc

Grade Last Price % Change Price Change
B 23.98 6.96% 1.56
IMGO closed up 6.96 percent on Wednesday, August 4, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical IMGO trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Shooting Star Candlestick Bearish 6.96%
Lizard Bearish Bearish Day Trade Setup 6.96%
New 52 Week Closing High Bullish 6.96%
Older End-of-Day Signals for IMGO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 16 hours ago
Possible Inside Day about 17 hours ago
60 Minute Opening Range Breakout about 20 hours ago
Down 3% about 21 hours ago
Down 2 % about 21 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Classification

Keywords: Bone Marrow Blood Molecule Product Myelofibrosis Blood Disorders Hematopathology Myeloproliferative Neoplasm Polycythemia Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis Thrombocythemia

Is IMGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.07
52 Week Low 14.99
Average Volume 90,119
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 18.32
Average True Range 1.81
ADX 0.0
+DI 40.17
-DI 4.45
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 1.11
MACD Signal Line 0.36
MACD Histogram 0.7505
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.55
Resistance 3 (R3) 27.30 25.86 26.96
Resistance 2 (R2) 25.86 24.95 25.99 26.76
Resistance 1 (R1) 24.92 24.39 25.39 25.17 26.56
Pivot Point 23.48 23.48 23.72 23.61 23.48
Support 1 (S1) 22.54 22.57 23.01 22.79 21.40
Support 2 (S2) 21.10 22.01 21.23 21.20
Support 3 (S3) 20.16 21.10 21.01
Support 4 (S4) 20.41